1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
- 2015
- Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
- Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours - A prognostic test after surgical resection.
- 2014
- Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.
- 2013
- Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
- 2011
- Fusion Gene Microarray Reveals Cancer Type-Specificity Among Fusion Genes
- 2010
- Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group.
- 2009
- Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
- Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors